Sign In
Buy AVXL
$2.65
-0.140 (-5.03%)
At Close: Jun 03, 2026
ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management
12:21pm, Tuesday, 15'th Oct 2024 InvestorsHub
ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management Commercial Drone market expected to grow at 23.7 CAGR (Compound Annual Growth Rate) through 2030 Miami, FL -- InvestorsHub NewsWire - October 15, 2024 - EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on ZenaTech, Inc. (NASDAQ: ZENA). ZenaTech, Inc. (NASDAQ:...
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
07:30am, Tuesday, 03'rd Sep 2024
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript
12:19pm, Tuesday, 06'th Aug 2024
Anavex Life Sciences Corp. (NASDAQ:AVXL ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and CEO
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
07:30am, Tuesday, 06'th Aug 2024
Company to host a webcast today at 8:30 a.m. Eastern Time
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
07:30am, Thursday, 01'st Aug 2024
Webcast and Conference Call To be Held Tuesday, August 6, 2024, 8:30 am ET Webcast and Conference Call To be Held Tuesday, August 6, 2024, 8:30 am ET
ANAVEX ® 2-73 corrects directly to humans' translatable EEG biomarkers in a model of Fragile X Syndrome (FXS)
Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
05:00pm, Sunday, 28'th Jul 2024
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
07:30am, Thursday, 20'th Jun 2024
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Anavex Life Sciences Announces Expansion of Leadership Team
07:30am, Wednesday, 22'nd May 2024
Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global Healthcare Systems Strengthening Operational Efficiency and Execution towards
Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 15'th May 2024
Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
07:30am, Tuesday, 14'th May 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeut
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal secur
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal secur
LOS ANGELES, CA / ACCESSWIRE / May 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anave
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal secur
